FAKTOR OPTIONSSCHEIN - FRESENIUS MEDICAL CARE Stock

Certificat

DE000PF2FMS7

Market Closed - Deutsche Boerse AG 15:20:31 2024-06-25 EDT
1.45 EUR +1.40% Intraday chart for FAKTOR OPTIONSSCHEIN - FRESENIUS MEDICAL CARE
Current month+17.89%
1 month+16.94%
Date Price Change
24-06-25 1.45 +1.40%
24-06-24 1.43 -2.05%
24-06-21 1.46 +3.55%
24-06-20 1.41 -1.40%
24-06-19 1.43 +2.88%

Delayed Quote Deutsche Boerse AG

Last update June 25, 2024 at 03:20 pm

More quotes

Static data

Product typeExotische Produkte
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PF2FMS
ISINDE000PF2FMS7
Date issued 2019-06-28
Strike 36.35
Maturity Unlimited
Parity 1 : 1
Emission price 2
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 5.01
Lowest since issue 1.08
Spread 0.04
Spread %2.70%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
35.67 EUR
Average target price
39.97 EUR
Spread / Average Target
+12.07%
Consensus